Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | May 05, 2020 | May 07, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GILEAD SCIENCES, INC.
Report date May 05, 2020 · Filed May 07, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 129,052 |
Reported balance
After 2020-05-05 transaction · row 1
1 source rowRow 1 · 2020-05-05 · Exercise / conversion · Acquired 2,270 · Balance 129,052 F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-05-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-05-05 · Exercise / conversion · Disposed 2,270 · Balance 0 F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: 100% of the restricted stock units vested on May 5, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2: 100% of the restricted stock units vested on May 5, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2008 Filed May 27, 2008 17:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 15,000 | $53.48 | $802,200.00 |
DisclosureSEC source: 0001179110-08-010638 · edgar.xml · nonDerivative · entry 8 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,268 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.49 | $5,348.50 |
DisclosureSEC source: 0001179110-08-010638 · edgar.xml · nonDerivative · entry 7 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,268 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 200 | $53.53 | $10,706.00 |
DisclosureSEC source: 0001179110-08-010638 · edgar.xml · nonDerivative · entry 6 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,368 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.54 | $5,353.50 |
DisclosureSEC source: 0001179110-08-010638 · edgar.xml · nonDerivative · entry 5 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,568 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 5,000 | $53.56 | $267,800.00 |
DisclosureSEC source: 0001179110-08-010638 · edgar.xml · nonDerivative · entry 4 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,668 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.63 | $5,363.00 |
DisclosureSEC source: 0001179110-08-010638 · edgar.xml · nonDerivative · entry 3 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,668 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 132 | $53.67 | $7,084.44 |
DisclosureSEC source: 0001179110-08-010638 · edgar.xml · nonDerivative · entry 2 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,768 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.68 | $5,367.80 |
DisclosureSEC source: 0001179110-08-010638 · edgar.xml · nonDerivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,900 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.18 | $5,317.50 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 11 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 700 | $53.18 | $37,226.00 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 10 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,100 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,200 | $53.19 | $63,828.00 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 9 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,800 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,500 | $53.20 | $79,800.00 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 8 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,000 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,700 | $53.21 | $90,457.00 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 7 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,500 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 200 | $53.22 | $10,643.00 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 6 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,200 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 600 | $53.22 | $31,932.00 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 5 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,400 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.23 | $5,322.50 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 4 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,000 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 300 | $53.23 | $15,969.00 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 3 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,100 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.24 | $5,323.70 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 2 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,400 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.25 | $5,325.00 |
DisclosureSEC source: 0001179110-08-010642 · edgar.xml · nonDerivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,500 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.27 | $5,327.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 25 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,600 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 200 | $53.28 | $10,656.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 24 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,700 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.29 | $5,328.90 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 23 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,900 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 300 | $53.29 | $15,987.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 22 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,000 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 300 | $53.30 | $15,988.50 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 21 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,300 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.30 | $5,329.90 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 20 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,600 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 200 | $53.30 | $10,660.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 19 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,700 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.31 | $5,331.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 18 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,900 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.32 | $5,331.80 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 17 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,000 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,200 | $53.32 | $63,984.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 16 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,100 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 200 | $53.33 | $10,665.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 15 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,300 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.33 | $5,332.80 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 14 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,500 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 299 | $53.33 | $15,945.67 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 13 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,600 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 7,600 | $53.34 | $405,384.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 12 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,899 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 700 | $53.35 | $37,341.50 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 11 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,499 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.35 | $5,334.70 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 10 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,199 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.35 | $5,334.80 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 9 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,299 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.35 | $5,334.90 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 8 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,399 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 7,500 | $53.35 | $400,125.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 7 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,499 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.36 | $5,335.50 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 6 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,999 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.36 | $5,336.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 5 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,099 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 280 | $53.37 | $14,942.20 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 4 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,199 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 11,072 | $53.37 | $590,912.64 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 3 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,479 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 200 | $53.38 | $10,675.00 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 2 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,551 Read SEC document |
| May 22, 2008 Filed May 27, 2008 17:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $53.38 | $5,337.80 |
DisclosureSEC source: 0001179110-08-010644 · edgar.xml · nonDerivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,751 Read SEC document |
| May 08, 2008 Filed May 9, 2008 23:17 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $53.23 | $0.00 |
DisclosureSEC source: 0001179110-08-009321 · edgar.xml · derivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2018-05-08 F1 · derivative.exercise_date: Options vest quarterly over a period of one year from date of grant. Read SEC document |
| June 28, 2007 Filed Jul 2, 2007 19:26 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Shares · Derivative | 757.77 | $0.00 Strike: $39.59 | $0.00 |
DisclosureSEC source: 0001179110-07-014125 · edgar.xml · derivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757.77 Underlying: Common Stock · 757.77 shares Expires not disclosed F1 · derivative.exercise_price: All shares and dollar amounts reflect a two-for-one split that was effected on June 22, 2007 benefiting all shareholders of record as of May 24, 2007. F2 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock over five years when the reporting person reaches the age of 70. F2 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock over five years when the reporting person reaches the age of 70. Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $57.35 | $0.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · derivative · entry 32 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2016-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options are 100% vested on date of grant. Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $57.36 | $0.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · derivative · entry 31 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2016-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options are 100% vested on date of grant. Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 26,250 | $0.00 Strike: $38.87 | $0.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · derivative · entry 30 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,250 shares Expires 2015-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options are 100% vested on date of grant. Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · derivative · entry 29 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,600 Underlying: Common Stock · 18,000 shares Expires 2012-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vest 5% quarterly over five years beginning from date of grant. The option will be fully vested on October 25, 2007. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.